Evgen Pharma

Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products.
Type
Public
HQ
Liverpool, GB
Founded
2007
Size (employees)
2 (est)
Evgen Pharma was founded in 2007 and is headquartered in Liverpool, GB

Evgen Pharma Office Locations

Evgen Pharma has offices in Liverpool, London
Liverpool, GB
London, GB

Evgen Pharma Metrics

Evgen Pharma Summary

Market capitalization

£20.1 M

Closing share price

£0.278
Evgen Pharma's current market capitalization is £20.1 M.

Evgen Pharma Market Value History

Evgen Pharma Online Presence

Evgen Pharma Company Life

You may also be interested in